COGNITIVE DEBRIEFING OF THE ADVANCED SYSTEMIC MASTOCYTOSIS SYMPTOM ASSESSMENT FORM (ADVSM-SAF)

被引：0
|
作者：
Taylor, F. [1 ]
Kreil, S. [2 ]
Reiter, A. [2 ]
Horny, H. [3 ]
Evans, E. [4 ]
Mazar, I [1 ]
McNamara, P. [4 ]
Boral, A. [4 ]
Lamoureux, R. E. [1 ]
Shields, A. [1 ]
Gotlib, J. [5 ]
机构：
[1] Adelphi Values, Boston, MA USA
[2] Univ Hosp Mannheim, Mannheim, Germany
[3] Ludwig Maximilians Univ Munchen, Munich, Germany
[4] Blueprint Med, Cambridge, MA USA
[5] Stanford Canc Ctr, Stanford, CA USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRM136
引用
收藏
页码：A335 / A336
页数：2
相关论文
共 42 条
  • [21] Avapritinib in Patients With Advanced Systemic Mastocytosis (AdvSM): Efficacy and Safety Analyses from the Phase 2 PATHFINDER Study With 2-Year Follow-Up
    Gotlib, Jason
    Reiter, Andreas
    Radia, Deepti H.
    Deininger, Michael W.
    George, Tracy I.
    Panse, Jens
    Vannucchi, Alessandro M.
    Platzbecker, Uwe
    Alvarez-Twose, Ivan
    Mital, Andrzej
    Hermine, Olivier
    Dybedal, Ingunn
    Hexner, Elizabeth O.
    Span, Lambert
    Mesa, Ruben
    Bose, Prithviraj
    Pettit, Kristen M.
    Oh, Stephen T.
    Lin, Hui-Min
    Dimitrijevic, Sasa
    Munoz-Gonzalez, Javier I.
    DeAngelo, Daniel J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S388 - S389
  • [22] Item nonresponse on the Myeloproliferative Neoplasms Symptom Assessment Form (MPN-SAF): a comparison of missing data strategies
    Mazza, Gina L.
    Kunze, Katie L.
    Langlais, Blake T.
    Kosiorek, Heidi E.
    DeWees, Todd A.
    Geyer, Holly L.
    Scherber, Robyn M.
    Mesa, Ruben A.
    Dueck, Amylou C.
    LEUKEMIA & LYMPHOMA, 2019, 60 (07) : 1789 - 1795
  • [23] The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): An International Prospective Validation Trial In 402 Patients
    Scherber, Robyn
    Dueck, Amylou
    Johansson, Peter L.
    Barbui, Tiziano
    Barosi, Giovanni
    Vannucchi, Alessandro M.
    Passamonti, Francesco
    Andreasson, Bjorn
    Ferarri, Maria L.
    Rambaldi, Alessandro
    Samuelsson, Jan
    Birgegard, Gunnar
    Tefferi, Ayalew
    Harrison, Claire N.
    Radia, Deepti
    Mesa, Ruben A.
    BLOOD, 2010, 116 (21) : 1666 - 1667
  • [24] THE MYELOPROLIFERATIVE NEOPLASM SYMPTOM ASSESSMENT FORM (MPN-SAF): PROSPECTIVE VALIDATION OF AN EVIDENCE BASED MPN SPECIFIC INSTRUMENT
    Mesa, R.
    Scherber, R.
    Dueck, A.
    Camoriano, J.
    Gentry, A.
    Reeder, C.
    Baumgartner, K.
    Jones, S.
    Radia, D.
    Tefferi, A.
    Harrison, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 405 - 405
  • [25] The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): International Prospective Validation and Reliability Trial in 402 patients
    Scherber, Robyn
    Dueck, Amylou C.
    Johansson, Peter
    Barbui, Tiziano
    Barosi, Giovanni
    Vannucchi, Alessandro M.
    Passamonti, Francesco
    Andreasson, Bjorn
    Ferarri, Maria L.
    Rambaldi, Alessandro
    Samuelsson, Jan
    Birgegard, Gunnar
    Tefferi, Ayalew
    Harrison, Claire N.
    Radia, Deepti
    Mesa, Ruben A.
    BLOOD, 2011, 118 (02) : 401 - 408
  • [26] Using Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF) to Evaluate Quality of Life for MPN Patients in Qatar
    Yassin, Mohamed A.
    El-Ayoubi, Hanadi Rafii
    Al-Dewik, Nader
    BLOOD, 2012, 120 (21)
  • [27] A Phase 2 Study of Bezuclastinib (CGT9486), an Oral, Selective, and Potent KIT D816V Inhibitor, in Adult Patients with Advanced Systemic Mastocytosis (AdvSM)
    Gotlib, Jason
    George, Tracy I.
    Deininger, Michael W.
    Tashi, Tsewang
    Pullarkat, Vinod A.
    Bose, Prithviraj
    Payumo, Francis
    Pilla, Amanda
    Jolin, Hina
    Sachs, Jessica
    DeAngelo, Daniel J.
    BLOOD, 2021, 138
  • [28] Myeloproliferative Neoplasm Symptom Assessment Form - Total Symptom Score (MPN-SAF TSS) questionnaire: translation, cultural adaptation and validation to Brazilian Portuguese
    Guarana, Mariana
    Soares, Andrea
    Daumas, Adelmo
    Biasoli, Irene
    Solza, Cristiana
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2022, 44 (03) : 321 - 327
  • [29] Clinical Activity in a Phase 1 Study of Blu-285, a Potent, Highly-Selective Inhibitor of KIT D816V in Advanced Systemic Mastocytosis (AdvSM)
    DeAngelo, Daniel J.
    Quiery, Albert Thomas
    Radia, Deepti
    Drummond, Mark W.
    Gotlib, Jason
    Robinson, William A.
    Hexner, Elizabeth
    Verstovsek, Srdan
    Shi, Hongliang
    Alvarez-Diez, Terri
    Schmidt-Kittler, Oleg
    Evans, Erica
    Healy, Mary Ellen
    Wolf, Beni B.
    Deininger, Michael W.
    BLOOD, 2017, 130
  • [30] Efficacy and Safety of Avapritinib as First-Line Treatment (or alternatively: First-line Treatment) of Patients with advanced systemic Mastocytosis (AdvSM): Results from the EXPLORER and PATHFINDER clinical Trials
    Reiter, A.
    Radia, D. H.
    Drummond, M. W.
    Deininger, M. W.
    George, T. I.
    Dimitrijevic, S.
    Lin, H. -M.
    Gotlib, J.
    DeAngelo, D. J.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 23 - 24
12345